Cargando…
A prognostic model for ovarian cancer
About 6000 women in the United Kingdom develop ovarian cancer each year and about two-thirds of the women will die from the disease. Establishing the prognosis of a woman with ovarian cancer is an important part of her evaluation and treatment. Prognostic models and indices in ovarian cancer should...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375096/ https://www.ncbi.nlm.nih.gov/pubmed/11592763 http://dx.doi.org/10.1054/bjoc.2001.2030 |
_version_ | 1782154576319741952 |
---|---|
author | Clark, T G Stewart, M E Altman, D G Gabra, H Smyth, J F |
author_facet | Clark, T G Stewart, M E Altman, D G Gabra, H Smyth, J F |
author_sort | Clark, T G |
collection | PubMed |
description | About 6000 women in the United Kingdom develop ovarian cancer each year and about two-thirds of the women will die from the disease. Establishing the prognosis of a woman with ovarian cancer is an important part of her evaluation and treatment. Prognostic models and indices in ovarian cancer should be developed using large databases and, ideally, with complete information on both prognostic indicators and long-term outcome. We developed a prognostic model using Cox regression and multiple imputation from 1189 primary cases of epithelial ovarian cancer (with median follow-up of 4.6 years). We found that the significant (P≤ 0.05) prognostic factors for overall survival were age at diagnosis, FIGO stage, grade of tumour, histology (mixed mesodermal, clear cell and endometrioid versus serous papillary), the presence or absence of ascites, albumin, alkaline phosphatase, performance status on the ZUBROD-ECOG-WHO scale, and debulking of the tumour. This model is consistent with other models in the ovarian cancer literature; it has better predictive ability and, after simplification and validation, could be used in clinical practice. http://www.bjcancer.com © 2001 Cancer Research Campaignhttp://www.bjcancer.com |
format | Text |
id | pubmed-2375096 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23750962009-09-10 A prognostic model for ovarian cancer Clark, T G Stewart, M E Altman, D G Gabra, H Smyth, J F Br J Cancer Regular Article About 6000 women in the United Kingdom develop ovarian cancer each year and about two-thirds of the women will die from the disease. Establishing the prognosis of a woman with ovarian cancer is an important part of her evaluation and treatment. Prognostic models and indices in ovarian cancer should be developed using large databases and, ideally, with complete information on both prognostic indicators and long-term outcome. We developed a prognostic model using Cox regression and multiple imputation from 1189 primary cases of epithelial ovarian cancer (with median follow-up of 4.6 years). We found that the significant (P≤ 0.05) prognostic factors for overall survival were age at diagnosis, FIGO stage, grade of tumour, histology (mixed mesodermal, clear cell and endometrioid versus serous papillary), the presence or absence of ascites, albumin, alkaline phosphatase, performance status on the ZUBROD-ECOG-WHO scale, and debulking of the tumour. This model is consistent with other models in the ovarian cancer literature; it has better predictive ability and, after simplification and validation, could be used in clinical practice. http://www.bjcancer.com © 2001 Cancer Research Campaignhttp://www.bjcancer.com Nature Publishing Group 2001-09 /pmc/articles/PMC2375096/ /pubmed/11592763 http://dx.doi.org/10.1054/bjoc.2001.2030 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Clark, T G Stewart, M E Altman, D G Gabra, H Smyth, J F A prognostic model for ovarian cancer |
title | A prognostic model for ovarian cancer |
title_full | A prognostic model for ovarian cancer |
title_fullStr | A prognostic model for ovarian cancer |
title_full_unstemmed | A prognostic model for ovarian cancer |
title_short | A prognostic model for ovarian cancer |
title_sort | prognostic model for ovarian cancer |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375096/ https://www.ncbi.nlm.nih.gov/pubmed/11592763 http://dx.doi.org/10.1054/bjoc.2001.2030 |
work_keys_str_mv | AT clarktg aprognosticmodelforovariancancer AT stewartme aprognosticmodelforovariancancer AT altmandg aprognosticmodelforovariancancer AT gabrah aprognosticmodelforovariancancer AT smythjf aprognosticmodelforovariancancer AT clarktg prognosticmodelforovariancancer AT stewartme prognosticmodelforovariancancer AT altmandg prognosticmodelforovariancancer AT gabrah prognosticmodelforovariancancer AT smythjf prognosticmodelforovariancancer |